Literature DB >> 24788996

Cellular and humoral immune responses during tuberculosis infection: useful knowledge in the era of biological agents.

Andrea Matucci1, Enrico Maggi, Alessandra Vultaggio.   

Abstract

In this review, recent insights into innate and adaptive cellular and humoral immune response to Mycobacterium tuberculosis (Mtb) are discussed and the role of specific cytokines such as tumor necrosis factor-α (TNF-α) is highlighted. According to recent findings, the immune system plays a key role in avoiding mycobacteria dissemination. The importance of different cell types (macrophages, dendritic cells, interferon-γ-producing T cells) as well as the production of proinflammatory cytokines such as interleukin 6 (IL-6), IL-12, and IL-23/IL-17 have been demonstrated. Alveolar macrophages are considered the first cells infected by Mtb during respiratory infection. Mtb proliferates within alveolar macrophages and dendritic cells and induces the release of cytokines such as TNF-α, IL-1, IL-6, and IL-12. Toll-like receptors-stimulated dendritic cells link innate and adaptive immunity by promoting polarization of effector T cells. The efficient induction of Th1 immunity is decisive in defense against Mtb. In fact, host effector immune response against Mtb is related to the presence of a Th1 response. The definition of the cellular and molecular mechanisms involved in the immune response to Mtb can be helpful in developing new preventive strategies to avoid infection relapse, particularly in patients treated with biological agents.

Entities:  

Keywords:  LATENT TUBERCULOSIS; MYCOBACTERIUM; T CELLS; TUMOR NECROSIS FACTOR-α BLOCKERS

Mesh:

Substances:

Year:  2014        PMID: 24788996     DOI: 10.3899/jrheum.140098

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  15 in total

1.  Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis.

Authors:  Nathan C Bahr; Ryan Halupnick; Grace Linder; Reuben Kiggundu; Henry W Nabeta; Darlisha A Williams; Abdu K Musubire; Bozena M Morawski; Srinand Sreevatsan; David B Meya; Joshua Rhein; David R Boulware
Journal:  Biomark Med       Date:  2018-06-01       Impact factor: 2.851

2.  Murine Flt3 ligand-generated plasmacytoid and conventional dendritic cells display functional differentiation in activation, inflammation, and antigen presentation during BCG infection in vitro.

Authors:  Chuang Meng; Xiaoyan Wang; Zhengzhong Xu; Maozhi Hu; Jiaying Liu; Zhiming Pan; Xiang Chen; Xinan Jiao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-08-05       Impact factor: 2.416

3.  Recognition of Candida albicans by gingival fibroblasts: The role of TLR2, TLR4/CD14, and MyD88.

Authors:  Claudia Ramos Pinheiro; Ana Lúcia Coelho; Carine Ervolino de Oliveira; Thaís Helena Gasparoto; Gustavo Pompermaier Garlet; João Santana Silva; Carlos Ferreira Santos; Karen Angélica Cavassani; Cory M Hogaboam; Ana Paula Campanelli
Journal:  Cytokine       Date:  2017-11-09       Impact factor: 3.861

4.  Genetic polymorphisms of CCL1 rs2072069 G/A and TLR2 rs3804099 T/C in pulmonary or meningeal tuberculosis patients.

Authors:  Yue Zhao; Hui Bu; Kun Hong; Hua Yin; Yue-Li Zou; Shu-Jun Geng; Ming-Ming Zheng; Jun-Ying He
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach.

Authors:  R Logesh; V Lavanya; Shazia Jamal; Neesar Ahmed
Journal:  Appl Biochem Biotechnol       Date:  2021-11-24       Impact factor: 2.926

Review 6.  Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosis.

Authors:  Abualgasim Elgaili Abdalla; Qiming Li; Longxiang Xie; Jianping Xie
Journal:  Int J Biol Sci       Date:  2015-01-05       Impact factor: 6.580

7.  The variations of IL-23R are associated with susceptibility and severe clinical forms of pulmonary tuberculosis in Chinese Uygurs.

Authors:  Daobin Jiang; Atikaimu Wubuli; Xin Hu; Syed Ikramullah; Abudoujilili Maimaiti; Wenbao Zhang; Qimanguli Wushouer
Journal:  BMC Infect Dis       Date:  2015-12-01       Impact factor: 3.090

8.  Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis.

Authors:  Xuezhi Wang; Shuangshuang Chen; Yongjuan Xu; Huajun Zheng; Tongyang Xiao; Yuqing Li; Xing Chen; Mingxiang Huang; Haifeng Zhang; Xijing Fang; Yi Jiang; Machao Li; Haican Liu; Kanglin Wan
Journal:  Emerg Microbes Infect       Date:  2017-06-07       Impact factor: 7.163

Review 9.  Hypersensitivity and Immune-related Adverse Events in Biologic Therapy.

Authors:  Jamie L Waldron; Stephen A Schworer; Mildred Kwan
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-28       Impact factor: 8.667

10.  Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.

Authors:  Ning-Kui Niu; Juan-Juan Yin; Yin-Xue Yang; Zi-Li Wang; Zhi-Wei Zhou; Zhi-Xu He; Xiao-Wu Chen; Xueji Zhang; Wei Duan; Tianxin Yang; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-08-07       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.